224 related articles for article (PubMed ID: 38136164)
1. A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration.
Berrino E; Carradori S; Carta F; Melfi F; Gallorini M; Poli G; Tuccinardi T; Fernández-Bolaños JG; López Ó; Petzer JP; Petzer A; Guglielmi P; Secci D; Supuran CT
Antioxidants (Basel); 2023 Nov; 12(12):. PubMed ID: 38136164
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases?
Carradori S; Fantacuzzi M; Ammazzalorso A; Angeli A; De Filippis B; Galati S; Petzer A; Petzer JP; Poli G; Tuccinardi T; Agamennone M; Supuran CT
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431918
[TBL] [Abstract][Full Text] [Related]
3. Recent Advancements and SAR Studies of Synthetic Coumarins as MAO-B Inhibitors: An Updated Review.
Kaur P; Rangra NK
Mini Rev Med Chem; 2024 May; ():. PubMed ID: 38778598
[TBL] [Abstract][Full Text] [Related]
4. Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (
Agamennone M; Fantacuzzi M; Carradori S; Petzer A; Petzer JP; Angeli A; Supuran CT; Luisi G
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431985
[TBL] [Abstract][Full Text] [Related]
5. Quinoline-sulfonamides as a multi-targeting neurotherapeutic for cognitive decline:
Jalil S; Hussain Z; Abid SMA; Hameed A; Iqbal J
RSC Adv; 2024 Mar; 14(13):8905-8920. PubMed ID: 38495980
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases.
Farina R; Pisani L; Catto M; Nicolotti O; Gadaleta D; Denora N; Soto-Otero R; Mendez-Alvarez E; Passos CS; Muncipinto G; Altomare CD; Nurisso A; Carrupt PA; Carotti A
J Med Chem; 2015 Jul; 58(14):5561-78. PubMed ID: 26107513
[TBL] [Abstract][Full Text] [Related]
7. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases.
Mathew B; Parambi DGT; Mathew GE; Uddin MS; Inasu ST; Kim H; Marathakam A; Unnikrishnan MK; Carradori S
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900177. PubMed ID: 31478569
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine and sertraline based multitarget inhibitors of cholinesterases and monoamine oxidase-A/B for the treatment of Alzheimer's disease: Synthesis, pharmacology and molecular modeling studies.
Nadeem MS; Khan JA; Rashid U
Int J Biol Macromol; 2021 Dec; 193(Pt A):19-26. PubMed ID: 34687762
[TBL] [Abstract][Full Text] [Related]
9. Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches.
Duarte P; Cuadrado A; León R
Handb Exp Pharmacol; 2021; 264():229-259. PubMed ID: 32852645
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF
Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders.
Quezada E; Rodríguez-Enríquez F; Laguna R; Cutrín E; Otero F; Uriarte E; Viña D
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361702
[TBL] [Abstract][Full Text] [Related]
12. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases.
Matos MJ; Janeiro P; González Franco RM; Vilar S; Tatonetti NP; Santana L; Uriarte E; Borges F; Fontenla JA; Viña D
Future Med Chem; 2014 Mar; 6(4):371-83. PubMed ID: 24635520
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the detailed structure-activity relationship of coumarins as Monoamine oxidase enzyme inhibitors-An updated review.
Koyiparambath VP; Prayaga Rajappan K; Rangarajan TM; Al-Sehemi AG; Pannipara M; Bhaskar V; Nair AS; Sudevan ST; Kumar S; Mathew B
Chem Biol Drug Des; 2021 Oct; 98(4):655-673. PubMed ID: 34233082
[TBL] [Abstract][Full Text] [Related]
15. Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation.
He Q; Liu J; Lan JS; Ding J; Sun Y; Fang Y; Jiang N; Yang Z; Sun L; Jin Y; Xie SS
Bioorg Chem; 2018 Dec; 81():512-528. PubMed ID: 30245233
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Enzymes Involved in Neurodegenerative Disorders and A
Arcone R; D'Errico A; Nasso R; Rullo R; Poli A; Di Donato P; Masullo M
Molecules; 2023 Aug; 28(17):. PubMed ID: 37687161
[TBL] [Abstract][Full Text] [Related]
17. Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson's Disease.
Duarte P; Michalska P; Crisman E; Cuadrado A; León R
Antioxidants (Basel); 2022 Jan; 11(2):. PubMed ID: 35204129
[TBL] [Abstract][Full Text] [Related]
18. Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases.
Vicente-Zurdo D; Brunetti L; Piemontese L; Guedes B; Cardoso SM; Chavarria D; Borges F; Madrid Y; Chaves S; Santos MA
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176018
[TBL] [Abstract][Full Text] [Related]
19. Chemical and Biological Evaluation of Novel 1
Kulikova LN; Purgatorio R; Beloglazkin AA; Tafeenko VA; Reza RG; Levickaya DD; Sblano S; Boccarelli A; de Candia M; Catto M; Voskressensky LG; Altomare CD
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175433
[TBL] [Abstract][Full Text] [Related]
20. Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents.
Pisani L; Farina R; Catto M; Iacobazzi RM; Nicolotti O; Cellamare S; Mangiatordi GF; Denora N; Soto-Otero R; Siragusa L; Altomare CD; Carotti A
J Med Chem; 2016 Jul; 59(14):6791-806. PubMed ID: 27347731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
